全文获取类型
收费全文 | 103301篇 |
免费 | 11266篇 |
国内免费 | 4905篇 |
专业分类
耳鼻咽喉 | 1075篇 |
儿科学 | 1955篇 |
妇产科学 | 1086篇 |
基础医学 | 6844篇 |
口腔科学 | 2180篇 |
临床医学 | 12870篇 |
内科学 | 12290篇 |
皮肤病学 | 1374篇 |
神经病学 | 3300篇 |
特种医学 | 4141篇 |
外科学 | 10686篇 |
综合类 | 22141篇 |
现状与发展 | 13篇 |
一般理论 | 17篇 |
预防医学 | 12966篇 |
眼科学 | 1500篇 |
药学 | 10754篇 |
119篇 | |
中国医学 | 8661篇 |
肿瘤学 | 5500篇 |
出版年
2024年 | 509篇 |
2023年 | 1579篇 |
2022年 | 3262篇 |
2021年 | 4155篇 |
2020年 | 3651篇 |
2019年 | 2229篇 |
2018年 | 2790篇 |
2017年 | 3183篇 |
2016年 | 2593篇 |
2015年 | 4284篇 |
2014年 | 5354篇 |
2013年 | 6911篇 |
2012年 | 8710篇 |
2011年 | 9016篇 |
2010年 | 7969篇 |
2009年 | 7174篇 |
2008年 | 7244篇 |
2007年 | 6957篇 |
2006年 | 6183篇 |
2005年 | 4947篇 |
2004年 | 3633篇 |
2003年 | 3017篇 |
2002年 | 2446篇 |
2001年 | 2320篇 |
2000年 | 1678篇 |
1999年 | 978篇 |
1998年 | 545篇 |
1997年 | 528篇 |
1996年 | 511篇 |
1995年 | 442篇 |
1994年 | 320篇 |
1993年 | 323篇 |
1992年 | 359篇 |
1991年 | 312篇 |
1990年 | 281篇 |
1989年 | 312篇 |
1988年 | 259篇 |
1987年 | 257篇 |
1986年 | 232篇 |
1985年 | 232篇 |
1984年 | 187篇 |
1983年 | 167篇 |
1982年 | 123篇 |
1981年 | 127篇 |
1980年 | 86篇 |
1979年 | 121篇 |
1978年 | 89篇 |
1977年 | 102篇 |
1976年 | 80篇 |
1975年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
Jonas T. Johnson MD Editor John K. Niparko MD Editor-in-Chief Paul A. Levine MD Editor David W. Kennedy MD Editor Pete Weber MD Editor-in-Chief Randal S. Weber MD Editor Michael S. Benninger MD Past Editor in Chief Richard M. Rosenfeld MD MPH Editor in Chief Robert J. Ruben MD Editor in Chief Richard J.H. Smith MD Editor in Chief Robert Thayer Sataloff MD DMA Editor in Chief Neil Weir MA FRCS Editor Emeritus 《Otolaryngology--head and neck surgery》2006,135(6):829-830
63.
64.
Gall bladder hydatid cyst is a rare entity. Concurrent occurrence of gall blader hydatid cysts along with liver cysts, especially with the biliary channels clear of cysts, is very rare. We report a 27-year-old man with a gall bladder hydatid cyst that was diagnosed only after opening the resected specimen of the gall bladder. 相似文献
65.
Kiyoshi Hashizume Kazuo Ichikawa Satoru Suzuki Teiji Takeda Keishi Yamauchi Mutsuhiro Kobayashi Xiao-Yun MA 《Journal of bone and mineral metabolism》1992,10(2):39-49
Calorie restriction is important in managing patients with maturity onset diabetes mellitus (NIDDM). The effect of such restriction
on calcium metabolism is not known. The objective of this study was to determine whether patients on calorie restricted diets
would show any modification of parathyroid hormone (PTH) and calcitonin (CTN).
The serum levels of PTH and CTN were measured by radioimmunoassays in 269 patients with NIDDM. The patients were divided into
two groups depending on the intake of calorie, and PTH and CTN were monitored for 2 years. Plasma levels of vitamin D were
measured by competitive protein binding assays before and after each program.
The level of PTH (520.8±266.0 pg/ml) (mean±S.D.) was significantly (P<0.01) higher in 109 diabetic patients whose calorie intake was restricted for 2 years (diet (D) group) as compared with that
(256.6±103.8 pg/ml) of 160 diabetic patients whose calorie intake was not restricted (non-diet (ND) group). The daily oral
calcium intake of the two groups did not differ significantly. We found no significant difference in the serum PTH level in
the ND groupVS. normal control subjects (248.8±98.4, N=78). The serum calcium concentration and the amount of calcium excreted in urine
were slightly but significantly (P<0.01) lower in the D than in the ND group. The rate of tubular reabsorption of phosphate (% TRP) was significantly lower
in the D group than that in the ND group (P<0.01). The serum CTN level was significantly (P<0.01) lower in the D group (33.9±11.3 pg/ml) than in the ND group (64.9±21.2 pg/ml) 2 years after each treatment. The plasma
1,25-(OH)2-vitamin D level was significantly (P<0.01) lower in the D group (22.2±6.6 pg/ml) than in the ND group (50.6±4.2 pg/ml). When
the restriction of calorie intake in the D group was canceled, their PTH levels decreased, which was accompanied by increase
in the 1,25-(OH)2-vitamin D levels, whereas their CTN levels were unchanged.
These observations suggested that a restricted calorie intake is a risk factor for secondary hyperparathyroidism as well as
for a low serum level of CTN in patients with NIDDM. 相似文献
66.
67.
F C Thien B A Atkinson A Khan J M Mencia-Huerta T H Lee 《The Journal of allergy and clinical immunology》1992,89(4):829-835
We have studied the effect of dietary fish oil supplementation (3.2 gm/day of eicosapentaenoic acid and 2.2 gm/day of docosahexaenoic acid) for 10 weeks on the antigen-induced, cutaneous late-phase response (LPR) in 16 atopic individuals. All subjects developed an LPR to intradermal allergen injection. The mean +/- SEM area of induration at 6 hours was 1840 +/- 472 mm2. A biopsy was performed at the LPR site at 6 hours. Subjects were then randomized to receive fish oil or placebo olive oil in a double-blind, parallel fashion, for 10 weeks. After the diet, there were no significant differences between fish oil and placebo treatment in the size of the immediate wheal-and-flare response or the extent of induration at 4 and 6 hours, as compared with prediet values in each group. Histologically, at 6 hours, there was a significant infiltrate into the allergen site compared with that of the control diluent site of total inflammatory cells (p less than 0.002) as well as of eosinophils (p less than 0.001). However, there were no significant differences when pre- and postdiet values were compared. Hence, we conclude that dietary fish oil supplementation does not inhibit the cutaneous LPR clinically or histologically. 相似文献
68.
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial 总被引:4,自引:0,他引:4
K C Petruk M West G Mohr B K Weir B G Benoit F Gentili L B Disney M I Khan M Grace R O Holness 《Journal of neurosurgery》1988,68(4):505-517
A multicenter, randomized placebo-controlled double-blind trial of nimodipine in poor-grade aneurysm patients was carried out in 17 Canadian hospitals. Of 188 patients enrolled in the trial, 32 were excluded for protocol violations and two were excluded due to statistical considerations, leaving 154 patients for valid outcome analysis. Nimodipine treatment was associated with a significantly better outcome (p less than 0.001): 21 (29.2%) of 72 nimodipine-treated patients had a good outcome at 3 months after subarachnoid hemorrhage (SAH) compared to eight (9.8%) of 82 placebo-treated patients. Delayed ischemic deficits from vasospasm alone were significantly less frequent in the nimodipine group (p less than 0.05) with permanent deficits occurring in five nimodipine-treated patients (6.9%) and in 22 placebo-treated patients (26.8%). Improvement in the good outcome rate and reduction in delayed ischemic deficits from vasospasm alone occurred in both Grade 3 and 4 patients, with no difference between nimodipine- and placebo-treated patients being found in Grade 5 patients. Repeat angiography after Day 4 was carried out in 124 patients. There was no significant difference in the incidence of moderate or severe diffuse spasm, which was seen in 64.3% of nimodipine-treated patients and 66.2% of placebo-treated patients. The authors conclude that nimodipine treatment in poor-grade patients with SAH results in an increase in the number of good outcomes and a reduction in the incidence of delayed neurological deterioration due to vasospasm. This effect occurs by a mechanism other than prevention of large-vessel spasm as visualized on angiography. 相似文献
69.
The nursing staff on an acute medical hospital ward elected to wear their own clothes to work for a period of 2 months. The trial was evaluated using a variety of research methods and it raised a number of issues about the role of uniform, about patients' perceptions of nurses and nurses' perceptions of their role. The study has led to questions being raised about the assumptions that are made if uniform is worn and the appropriateness of a uniform dress. 相似文献
70.
目的:分析74例更换起搏器时电极导线的各项参数的变化并探讨导线更换指标。方法:本组年龄12~87(62.8±18.4)岁,其中病窦综合征45例,房室传导阻滞29例,均为单腔VVI起搏。结果:至测量时原心室起搏电极导线的埋置时间60~148(97.4±22.8)月,首次埋置时起搏阈值为(0.48±0.24)V,更换时为(1.29±0.64)V(P(0.01),增加0.81V,增幅为168%,首次植入时R波幅为(7.8±3.6)mV,更换时为(5.9±3.4)mV(P(0.05)。植入时电极导线阻抗为(664±122)Ω,更换时阻抗为(726±148)Ω,增幅9.3%(P(0.05)。7例因起搏阈值大于2.0 V或阻抗大于1 250Ω而重新植入电极导线。原电极导线使用率为90.5%。结论:埋置起搏电极导线8~9年后,90.5%原电极导线仍在可使用的范围内,能否支持到再次更换需进一步随访。 相似文献